QUINCE THERAPEUTICS INC (QNCX)
US22053A1079 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -53.26M | -31.39M | -51.66M | -89.95M | -76.85M | |||
| Depreciation Amortization | 472.00K | 322.00K | 200.00K | 340.00K | 330.00K | |||
| Income Taxes - Deferred | 2.00K | -248.00K | -280.00K | N/A | N/A | |||
| Change In Working Capital | -2.17M | 2.01M | -9.74M | -4.26M | 10.23M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 24.52M | 11.01M | 17.44M | 30.93M | 15.47M | |||
| OPERATING CASH FLOW | -30.43M | -18.29M | -44.04M | -62.93M | -50.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -144.00K | -160.00K | -130.00K | -180.00K | -50.00K | |||
| Other Investing Activity | 16.58M | -5.60M | 18.14M | 59.13M | -52.38M | |||
| INVESTING CASH FLOW | 16.43M | -5.76M | 18.00M | 58.95M | -52.43M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.00K | -6.00K | -50.00K | 0.00 | -30.00K | |||
| Stock Issued/Repurchased | 284.00K | 149.00K | 760.00K | 6.81M | 118.91M | |||
| FINANCING CASH FLOW | -4.72M | 143.00K | 710.00K | 6.81M | 118.88M | |||
| Exchange Rate Effect | -241.00K | 80.00K | 180.00K | 60.00K | N/A | |||
| CHANGE IN CASH | -18.96M | -23.83M | -25.15M | 2.89M | 15.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.43M | -18.29M | -44.04M | -62.93M | -50.82M | |||
| Capital Expenditure | -144.00K | -160.00K | -130.00K | -180.00K | -50.00K | |||
| FREE CASH FLOW | -30.58M | -18.45M | -44.17M | -63.11M | -50.87M | |||
All data in USD